Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-02-07 Sale | 2024-02-08 7:19 pm | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 2,161 | $41.54 | $89,777 | 21,431 (Direct) | View |
2022-11-01 Sale | 2022-11-03 4:28 pm | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 25,000 | $30 | $750,005 | 167,765 (Direct) | View |
2022-10-04 Sale | 2022-10-06 4:59 pm | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 25,000 | $30 | $750,000 | 192,765 (Direct) | View |
2022-08-10 Sale | 2022-08-12 4:15 pm | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 55,000 | $40.5 | $2,227,624 | 217,765 (Direct) | View |
2022-08-05 Sale | 2022-08-09 9:23 pm | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 30,000 | $34.25 | $1,027,500 | 232,244 (Direct) | View |
2022-07-20 Sale | 2022-07-22 4:15 pm | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 25,000 | $30 | $750,000 | 142,474 (Direct) | View |
2022-07-05 Sale | 2022-07-07 4:06 pm | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 26,105 | $30.11 | $785,913 | 333,349 (Direct) | View |
2022-04-13 Sale | 2022-04-15 4:19 pm | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 45,000 | $34.65 | $1,559,093 | 192,855 (Direct) | View |
2022-03-29 Sale | 2022-03-31 4:05 pm | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 10,000 | $35 | $350,000 | 237,855 (Direct) | View |
2022-03-16 Sale | 2022-03-18 7:56 pm | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 45,000 | $31.11 | $1,400,009 | 513,730 (Direct) | View |
2022-03-09 Sale | 2022-03-11 4:08 pm | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 30,000 | $33.33 | $1,000,000 | 292,855 (Direct) | View |
2022-03-02 Sale | 2022-03-04 4:12 pm | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 25,000 | $30 | $750,000 | 322,855 (Direct) | View |
2022-02-09 Sale | 2022-02-11 6:46 pm | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 25,000 | $30 | $750,000 | 516,711 (Direct) | View |
2021-12-23 Sale | 2021-12-28 4:31 pm | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 10,000 | $35 | $350,027 | 747,857 (Direct) | View |
2021-12-21 Sale | 2021-12-23 5:14 pm | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 7,300 | $32.5 | $237,250 | 382,855 (Direct) | View |
2021-12-15 Sale | 2021-12-17 8:27 pm | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 37,700 | $30.85 | $1,163,198 | 1,186,327 (Direct) | View |
2021-11-10 Sale | 2021-11-15 4:18 pm | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 55,000 | $39.86 | $2,192,187 | 425,875 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-08-01 Disposition | 2024-08-05 4:30 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 887,422 | $0 | 0 (Direct) | View |
2024-02-06 Exercise | 2024-02-08 7:19 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 5,020 | $0 | 21,431 (Direct) | View |
2024-01-19 Option Award | 2024-01-23 5:50 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 87,573 | $0 | 87,573 (Direct) | View |
2023-02-06 Option Award | 2023-02-08 8:34 pm | N/A 2033-02-06 | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 99,103 | $0 | 99,103 (Direct) | View |
2022-11-01 Exercise | 2022-11-03 4:28 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 14,982 | $10.28 | 167,765 (Direct) | View |
2022-11-01 Exercise | 2022-11-03 4:28 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 10,018 | $3.5 | 167,765 (Direct) | View |
2022-11-01 Exercise | 2022-11-03 4:28 pm | N/A 2029-04-02 | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 25,000 | $0 | 167,765 (Direct) | View |
2022-10-04 Exercise | 2022-10-06 4:59 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 14,982 | $10.28 | 192,765 (Direct) | View |
2022-10-04 Exercise | 2022-10-06 4:59 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 10,018 | $3.5 | 192,765 (Direct) | View |
2022-10-04 Exercise | 2022-10-06 4:59 pm | N/A 2029-04-02 | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 25,000 | $0 | 192,765 (Direct) | View |
2022-08-10 Exercise | 2022-08-12 4:15 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 25,376 | $10.28 | 217,765 (Direct) | View |
2022-08-10 Exercise | 2022-08-12 4:15 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 29,624 | $3.5 | 217,765 (Direct) | View |
2022-08-10 Exercise | 2022-08-12 4:15 pm | N/A 2029-04-02 | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 55,000 | $0 | 217,765 (Direct) | View |
2022-08-05 Exercise | 2022-08-09 9:23 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 30,000 | $3.5 | 232,244 (Direct) | View |
2022-08-05 Exercise | 2022-08-09 9:23 pm | N/A 2029-04-02 | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 30,000 | $0 | 232,244 (Direct) | View |
2022-07-20 Exercise | 2022-07-22 4:15 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 25,000 | $3.5 | 142,474 (Direct) | View |
2022-07-20 Exercise | 2022-07-22 4:15 pm | N/A 2029-04-02 | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 25,000 | $0 | 142,474 (Direct) | View |
2022-07-05 Exercise | 2022-07-07 4:06 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 26,105 | $3.5 | 333,349 (Direct) | View |
2022-07-05 Exercise | 2022-07-07 4:06 pm | N/A 2029-04-02 | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 26,105 | $0 | 333,349 (Direct) | View |
2022-04-13 Exercise | 2022-04-15 4:19 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 45,000 | $3.5 | 192,855 (Direct) | View |
2022-04-13 Exercise | 2022-04-15 4:19 pm | N/A 2029-04-02 | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 45,000 | $0 | 192,855 (Direct) | View |
2022-03-29 Exercise | 2022-03-31 4:05 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 10,000 | $3.5 | 237,855 (Direct) | View |
2022-03-29 Exercise | 2022-03-31 4:05 pm | N/A 2029-04-02 | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 10,000 | $0 | 237,855 (Direct) | View |
2022-03-16 Exercise | 2022-03-18 7:56 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 45,000 | $3.5 | 513,730 (Direct) | View |
2022-03-16 Exercise | 2022-03-18 7:56 pm | N/A 2029-04-02 | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 45,000 | $0 | 513,730 (Direct) | View |
2022-03-09 Exercise | 2022-03-11 4:08 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 30,000 | $3.5 | 292,855 (Direct) | View |
2022-03-09 Exercise | 2022-03-11 4:08 pm | N/A 2029-04-02 | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 30,000 | $0 | 292,855 (Direct) | View |
2022-03-02 Exercise | 2022-03-04 4:12 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 25,000 | $3.5 | 322,855 (Direct) | View |
2022-03-02 Exercise | 2022-03-04 4:12 pm | N/A 2029-04-02 | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 25,000 | $0 | 322,855 (Direct) | View |
2022-02-09 Exercise | 2022-02-11 6:46 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 25,000 | $3.5 | 516,711 (Direct) | View |
2022-02-09 Option Award | 2022-02-11 6:46 pm | N/A 2032-02-09 | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 168,856 | $0 | 516,711 (Direct) | View |
2022-02-09 Exercise | 2022-02-11 6:46 pm | N/A 2029-04-02 | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 25,000 | $0 | 516,711 (Direct) | View |
2021-12-23 Exercise | 2021-12-28 4:31 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 10,000 | $3.5 | 747,857 (Direct) | View |
2021-12-23 Exercise | 2021-12-28 4:31 pm | N/A 2029-04-02 | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 10,000 | $0 | 747,857 (Direct) | View |
2021-12-21 Exercise | 2021-12-23 5:14 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 7,300 | $3.5 | 382,855 (Direct) | View |
2021-12-21 Exercise | 2021-12-23 5:14 pm | N/A 2029-04-02 | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 7,300 | $0 | 382,855 (Direct) | View |
2021-12-15 Exercise | 2021-12-17 8:27 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 37,700 | $3.5 | 1,186,327 (Direct) | View |
2021-12-15 Exercise | 2021-12-17 8:27 pm | N/A 2029-04-02 | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 37,700 | $0 | 1,186,327 (Direct) | View |
2021-11-10 Exercise | 2021-11-15 4:18 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 55,000 | $3.5 | 425,875 (Direct) | View |
2021-11-10 Exercise | 2021-11-15 4:18 pm | N/A 2029-04-02 | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 55,000 | $0 | 425,875 (Direct) | View |
2021-02-03 Option Award | 2021-02-05 6:51 pm | N/A 2031-02-03 | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 247,678 | $0 | 247,678 (Direct) | View |
2020-10-28 Option Award | 2020-10-30 8:14 pm | N/A 2030-10-28 | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 117,801 | $0 | 117,801 (Direct) | View |
Ownership | 2020-10-30 7:57 pm | N/A 2029-04-02 | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 0 | $0 | 641,166 (Direct) | View |